Exelixis, Inc. (EXEL) vs Solventum Corporation (SOLV)
A side-by-side comparison of Exelixis, Inc. and Solventum Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 21, 2026. Differences are shown without an overall score or investment verdict.
EXEL
Exelixis, Inc.
$54.08HealthcareDelayed quote: Aug 21, 2026, 4:00 PM EDT
SOLV
Solventum Corporation
$89.57HealthcareDelayed quote: Aug 21, 2026, 4:00 PM EDT
Total return — EXEL vs SOLV
growth of $100 · dividends reinvested · last 2yEXEL +127.4% (+50.8%/yr)SOLV +12.0% (+5.8%/yr)EXEL compounded faster over this window
EXEL SOLV
EXEL vs SOLV: by the numbers
- •SOLV is the larger company ($15.51B vs $13.59B market cap).
- •SOLV trades at the lower trailing earnings multiple (10.94 vs 16.95 P/E), one valuation lens rather than an overall verdict.
- •EXEL converts more revenue to profit (35.33% vs 17.26% net margin).
- •EXEL grew revenue faster over the past five years (16.06% vs 2.72% CAGR).
Metrics side by side
Valuation
| Metric | EXEL | SOLV |
|---|---|---|
| P/E ratio | 16.95 | 10.94 |
| Forward P/E | 18.14 | 12.46 |
| P/S ratio | 5.77 | 1.88 |
| P/B ratio | 7.62 | 3.25 |
| EV / EBITDA | 13.93 | 7.20 |
| FCF yield | 8.41% | N/A |
Profitability
| Metric | EXEL | SOLV |
|---|---|---|
| Gross margin | 96.48% | 54.69% |
| Operating margin | 39.88% | 24.99% |
| Net margin | 35.33% | 17.26% |
| ROE | 46.68% | 29.88% |
| ROIC | 37.87% | 15.85% |
Growth (annualized)
| Metric | EXEL | SOLV |
|---|---|---|
| Revenue CAGR (5Y) | 16.06% | 2.72% |
| EPS CAGR (5Y) | 51.51% | 6.26% |
| FCF CAGR (5Y) | 40.17% | N/A |
| Total return CAGR (5Y) | 24.00% | N/A |
Frequently asked
- Which has the lower trailing P/E, EXEL or SOLV?
- SOLV has the lower trailing P/E: EXEL trades at 16.95 and SOLV at 10.94. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, EXEL or SOLV?
- Over the past five years, EXEL grew revenue faster — EXEL at a 16.06% CAGR versus SOLV at 2.72%.
- Is EXEL or SOLV more profitable?
- EXEL runs the higher net margin — EXEL at 35.33% versus SOLV at 17.26%.
Go deeper
Dig into the metrics
Exelixis P/E ratioSolventum P/E ratioExelixis ROESolventum ROEExelixis operating marginSolventum operating marginExelixis revenue growthSolventum revenue growthExelixis free cash flowSolventum free cash flow
Exelixis & Solventum appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 21, 2026.